MeSH tree: C14.907.355.590
Researchers at Mass General Brigham Heart and Vascular Institute and collaborators have developed and validated a new genetic risk test that can estimate a person's inherited risk for eight common cardiovascular conditions, ...
Apr 29, 2026
0
9
Older adults recovering from serious blood clots often face long periods of hospitalization or rehabilitation due to a higher rate of recurrence. But a new study suggests that the choice of blood thinner may influence how ...
Apr 27, 2026
0
5
Blood clots that form in veins—known as venous thromboembolisms—are a leading cause of illness and death worldwide. Despite the serious threat they pose to human health, researchers have never fully understood why these clots ...
Apr 20, 2026
0
7
The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban is safer than rivaroxaban, ...
Mar 11, 2026
0
26
In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of anticoagulants, investigators found no evidence of an increase in patients' bleeding or clotting risks, ...
Mar 9, 2026
0
8
Early detection and prompt treatment of acute pulmonary embolism (PE), a sudden and potentially life‑threatening blood clot that blocks arteries in the lungs, is critical. Comprehensive recommendations for the evaluation, ...
Feb 19, 2026
0
9
Two new studies published in Anaesthesia analyzing pain and other factors connected with day surgery in the UK show that around one in eight patients having day-case surgery end up not going home and instead are admitted ...
Jan 7, 2026
0
7
The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered therapy for patients with epidermal growth factor receptor (EGFR)-mutated ...
Dec 23, 2025
0
14
Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to lower rates of new clots developing compared with stopping treatment, finds a US study published ...
Nov 12, 2025
0
13
When anesthesiologists lead the preoperative process, patients undergoing surgery for hip fractures—one of the leading causes of hospitalization in older adults—get to the operating room (OR) faster and have fewer complications, ...
Oct 13, 2025
0
13
